#36: A Novel Interactive Safety Graphic to Evaluate Potential Drug-Induced Hepatotoxicity
James Buchanan, PharmD
- Drug Safety Consultant
- Covilance LLC, United States
Dr. Buchanan has been in the pharmaceutical industry working in drug safety for over 30 years. He started his career at Genentech and led the drug safety departments at a number of subsequent companies, Gilead Sciences, Tularik and Nuvelo, before serving as the head of the medical and safety consulting group at BioSoteria. Dr. Buchanan is currently president of Covilance, LLC, a drug safety consulting service. He has also been teaching the DIA course on Advanced Signal Detection for a number of years and teaches drug safety at the UC Berkeley Extension program on clinical development.
Jeremy Wildfire, MSc
- Senior Data Scientist
- Rho, Inc. , United States
I have worked as a biostatistician for the NIAID funded Inner City Asthma Consortium (ICAC) for nearly 10 years. My work with ICAC has included the development of the Composite Asthma Severity Index, the first quantitative measure of asthma severity, and the analysis of multiple late-stage clinical trials for novel asthma treatments. I've paid special attention to statistical graphics and have worked created many interactive web-based tools for analyzing health-related data.